We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Fintel reports that on January 22, 2025, William Blair downgraded their outlook for Charles River Laboratories International (NYSE:CRL) from Outperform to Market Perform. Analyst Price Forecast ...
The firm decreased its portfolio allocation in CRL by 10.30% over the last quarter. (This description is provided by the company.) Charles River provides essential products and services to help ...
CRL has introduced Apollo for CRADL (Charles ... iteratively expanded platform gives clients greater access to data, products and services across the portfolio, enabling data-driven decision ...